NO20013257L - Beinstimulerende faktor - Google Patents

Beinstimulerende faktor

Info

Publication number
NO20013257L
NO20013257L NO20013257A NO20013257A NO20013257L NO 20013257 L NO20013257 L NO 20013257L NO 20013257 A NO20013257 A NO 20013257A NO 20013257 A NO20013257 A NO 20013257A NO 20013257 L NO20013257 L NO 20013257L
Authority
NO
Norway
Prior art keywords
stimulating factor
ser gly
subsequences
pro lys
bone stimulating
Prior art date
Application number
NO20013257A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013257D0 (no
Inventor
Cherk Shing Tam
Original Assignee
Osteopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteopharm Inc filed Critical Osteopharm Inc
Publication of NO20013257D0 publication Critical patent/NO20013257D0/no
Publication of NO20013257L publication Critical patent/NO20013257L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20013257A 1999-01-13 2001-06-29 Beinstimulerende faktor NO20013257L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/229,304 US6693081B2 (en) 1995-09-26 1999-01-13 Bone stimulating factor
PCT/CA2000/000031 WO2000042069A1 (en) 1999-01-13 2000-01-13 Bone stimulating factor

Publications (2)

Publication Number Publication Date
NO20013257D0 NO20013257D0 (no) 2001-06-29
NO20013257L true NO20013257L (no) 2001-08-17

Family

ID=22860649

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013257A NO20013257L (no) 1999-01-13 2001-06-29 Beinstimulerende faktor

Country Status (19)

Country Link
US (2) US6693081B2 (enExample)
EP (1) EP1161450A1 (enExample)
JP (1) JP2002538775A (enExample)
KR (1) KR20010101425A (enExample)
CN (1) CN1341120A (enExample)
AU (1) AU779261B2 (enExample)
BG (1) BG105682A (enExample)
BR (1) BR0007816A (enExample)
CA (1) CA2358908A1 (enExample)
CZ (1) CZ20012456A3 (enExample)
HU (1) HUP0105004A2 (enExample)
IL (1) IL143990A0 (enExample)
IS (1) IS5999A (enExample)
MA (1) MA25594A1 (enExample)
MX (1) MXPA01007043A (enExample)
NO (1) NO20013257L (enExample)
NZ (1) NZ512637A (enExample)
PL (1) PL349786A1 (enExample)
WO (1) WO2000042069A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693081B2 (en) * 1995-09-26 2004-02-17 Osteopharm Inc. Bone stimulating factor
AU5379200A (en) * 1999-06-02 2000-12-28 Osteopharm Inc. Bone stimulating factor
CA2490876A1 (en) * 2002-07-05 2004-02-19 Gaspardo Seminatrici S.P.A. A volumetric metering device for the metered delivery of granular and powdery materials, particularly for machines for distributing the said materials
AU2003272814A1 (en) 2003-10-02 2005-05-19 Ibrahim Al-Habdan Peptide for promoting healing of fractures
CA2838490A1 (en) * 2011-06-10 2012-12-13 Universite Libre De Bruxelles Targets and agents for the treatment of impaired bone fracture healing
CN103159762B (zh) * 2013-03-25 2015-04-15 华东理工大学 表吲哚二酮衍生物及其用途

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320118A (en) 1980-12-22 1982-03-16 Syntex (U.S.A.) Inc. Deca-, undeca-, dodeca- and tridecapeptides with thymic activity
US4897348A (en) 1983-08-25 1990-01-30 Sri International Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof
US4877864A (en) 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
US5354557A (en) 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5024841A (en) 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US5510418A (en) 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5264214A (en) 1988-11-21 1993-11-23 Collagen Corporation Composition for bone repair
FI903931A7 (fi) 1988-12-08 1990-08-08 Sandoz Ag Neutrofiiliaktivoiva peptidi-2
US5461034A (en) 1989-02-23 1995-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Osteogenic growth polypeptides identified from regenerating bone marrow
EP0513201A1 (en) 1990-02-01 1992-11-19 University Of South Florida Leukocyte-derived growth factor
CA2040264A1 (en) 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
ATE176239T1 (de) 1990-11-21 1999-02-15 Iterex Pharma Lp Synthese äquimolarer mischungen vielzähliger oligomere, speziell oligopeptidmischungen
US5776892A (en) * 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
ATE164167T1 (de) * 1990-12-21 1998-04-15 Curative Tech Inc Angiogene peptide
US5208219A (en) 1991-02-14 1993-05-04 Celtrix Pharmaceuticals Inc. Method for inducing bone growth
ATE139700T1 (de) 1991-02-15 1996-07-15 Takeda Chemical Industries Ltd Mit einem zellwachstumsfaktor bewirkte anregung von wachstum im knocheninneren
EP0504938A3 (en) 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
US5792664A (en) 1992-05-29 1998-08-11 The Rockefeller University Methods for producing and analyzing biopolymer ladders
NZ255041A (en) * 1992-07-13 1996-11-26 Bionebraska Inc Preparation of a recombinant single copy polypeptide or portion thereof modified with a terminal alpha amino carbon reactive group and reactive side chain groups involving biologically added protective groups
US5304542A (en) 1992-08-28 1994-04-19 University Of Louisville Research Foundation, Inc. Use of platelet factor 4 to inhibit osteoblast proliferation
US5578569A (en) 1993-03-12 1996-11-26 Tam; Cherk S. Method of increasing bone growth
IL108947A0 (en) 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
US5661127A (en) 1995-05-01 1997-08-26 The Regents Of The University Of California Peptide compositions with growth factor-like activity
US6352973B1 (en) 1995-06-07 2002-03-05 Osteopharm Inc. Bone stimulating factor
US6117839A (en) 1995-06-07 2000-09-12 Gensci Regeneration Sciences, Inc. Bone stimulating factor
US5880094A (en) 1995-06-07 1999-03-09 Osteopharm Limited Polypeptides that stimulate bone growth
US6693081B2 (en) * 1995-09-26 2004-02-17 Osteopharm Inc. Bone stimulating factor
ZA968062B (en) 1995-09-26 1997-06-18 Osteopharm Ltd Bone stimulating factor

Also Published As

Publication number Publication date
MXPA01007043A (es) 2002-03-27
CA2358908A1 (en) 2000-07-20
EP1161450A1 (en) 2001-12-12
PL349786A1 (en) 2002-09-09
NO20013257D0 (no) 2001-06-29
IL143990A0 (en) 2002-04-21
HUP0105004A2 (hu) 2002-04-29
KR20010101425A (ko) 2001-11-14
WO2000042069A1 (en) 2000-07-20
IS5999A (is) 2001-07-11
NZ512637A (en) 2003-08-29
JP2002538775A (ja) 2002-11-19
AU779261B2 (en) 2005-01-13
CN1341120A (zh) 2002-03-20
CZ20012456A3 (cs) 2002-02-13
US6693081B2 (en) 2004-02-17
BR0007816A (pt) 2002-12-31
US20020090671A1 (en) 2002-07-11
AU3028200A (en) 2000-08-01
US20040147450A1 (en) 2004-07-29
MA25594A1 (fr) 2002-12-31
BG105682A (en) 2003-04-30

Similar Documents

Publication Publication Date Title
Bork The modular architecture of a new family of growth regulators related to connective tissue growth factor
US4661111A (en) Polypeptide
ATE464067T1 (de) Bindegewebs wachstumsfaktor (ctgf)
DE10075019I2 (de) Neue Proteine mit TNF-Hemmender Wirkung und ihre Herstellung.
DE69942035D1 (de) Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
DE69435075D1 (de) , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
TR200102729T2 (tr) Platelet yapışmasını bloke etme amaçlı protein
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
EP1012173B1 (en) Isolated decapeptides which bind to hla molecules, and the use thereof
JPH10504518A (ja) Hla−a2分子と複合する腫瘍拒絶抗原前駆体由来の単離ペプチド
NO20014417L (no) Vaskul¶re adhesjonsmolekyler samt modulering av deres funksjon
NO20013257L (no) Beinstimulerende faktor
ATE63126T1 (de) Tetra- und penta-peptide mit der sequenz lysylarginyl-aspartyl, und ihre verwendung als antithrombotika.
RU98112759A (ru) Человеческий семафорин l (h-sema-l) и соответствующие семафорины в других видах
NO20011460L (no) Cytokinreseptor zalphall
ATE494301T1 (de) Alpha-fetoprotein-peptide und ihre verwendung
EA200100264A1 (ru) Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly
NO975565L (no) Benstimulerende faktor
ATE177843T1 (de) Peptomere mit erhöhter immunogenizität
WO1997012036A3 (en) Bone stimulating factor
NO942360L (no) Vaksine og polypeptider som er nyttige for denne
DE69939379D1 (de) Hemmstoff zur diagnose und behandlung von haemophilia a patienten
HUP9702500A2 (hu) Elhízás elleni proteinek
DE69534324D1 (de) Menschliche scf, eine spleissvariante davon,ihre pharmazeutische verwendung
WO1998054209A3 (en) Human mast cell function-associated antigen (mafa) and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application